Trial shows fewer HF hospitalizations in HFpEF ...

One woman spent years battling symptoms she couldn’t name—until a diagnosis and treatment finally brought clarity and renewed ...

Alpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q4 2025 Earnings Call Transcript March 26, 2026 Alpha Cognition Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.3 EPS, ...

Biomea Fusion, Inc. ( BMEA) Discusses Menin Inhibition Mechanism and Therapeutic Potential in Diabetes March 30, 2026 3:00 PM EDT Michael J. Hitchcock - Interim CEO & Director Ramses Erdtmann - ...

The cardiac myosin inhibitor gets a big win in the SCOUT-HCM trial ...

Dr. Reddy's, Sun Pharma, Zydus & others launch branded generics after patent expiry, targeting a ₹12,000-crore market ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ('Inhibikase” or 'Company”), a clinical-stage pharmaceutical company developing ...

The drug’s efficacy “looks to be highly competitive” and potentially better than rival pills from Novo and Lilly, BMO Capital ...

NASDAQ: MTVA Lili Elston: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we're very pleased you've joined us. The next ...

Structure Therapeutics' Phase 2 data for Aleniglipron show 16% weight loss at 44 weeks with strong tolerability and no safety ...

GLP-1 therapies have expanded beyond diabetes and obesity treatment, displaying vascular and potential mental health benefits ...

A 40–50% price drop in GLP-1 weight-loss drugs like Ozempic could boost access in India. Experts weigh in on benefits, risks, ...